Vaxxinity, Inc.
VAXX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $107,533 | $176,315 | $703,450 | $2,076,250 |
| - Cash | $4,931 | $33,475 | $144,885 | $31,143 |
| + Debt | $15,168 | $14,549 | $10,699 | $38,305 |
| Enterprise Value | $117,770 | $157,389 | $569,264 | $2,083,412 |
| Revenue | $0 | $0 | $66 | $557 |
| % Growth | – | -100% | -88.2% | – |
| Gross Profit | -$2,234 | -$1,684 | -$1,871 | $505 |
| % Margin | – | – | -2,834.8% | 90.7% |
| EBITDA | -$54,004 | -$73,024 | -$135,233 | -$38,058 |
| % Margin | – | – | -204,898.5% | -6,832.7% |
| Net Income | -$57 | -$75,210 | -$137,175 | -$39,957 |
| % Margin | – | – | -207,840.9% | -7,173.6% |
| EPS Diluted | -0.001 | -0.6 | -1.09 | -0.32 |
| % Growth | 99.9% | 45% | -240.6% | – |
| Operating Cash Flow | -$57,238 | -$55,928 | -$80,990 | -$33,910 |
| Capital Expenditures | -$803 | -$1,866 | -$1,318 | -$1,477 |
| Free Cash Flow | -$58,041 | -$57,794 | -$82,308 | -$35,387 |